DRAGARWQBSEDr Agarwals Eye Hospital Ltd-$HighNeutral
Announced Mon, 1 Jun · 13:16 IST

Notice convening the meeting of the unsecured creditors of the Company pursuant to the order of the Hon''ble Tribunal, Chennai Bench, is submitted.

Nclt Scheme FiledStrategic Transactions View source PDF

DRAGARWQ · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-0.9%1-day move
₹5080.00
prior close
₹5020.00
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.5+0.3+0.3+0.0-0.9+2.4-0.0-0.5-2.3-2.8-1.8-1.6
Up moveDown movePending
AI summary

Dr. Agarwal's Eye Hospital Limited (AEHL) has been directed by the NCLT Chennai Bench, via its order dated May 05, 2026, to convene a meeting of its unsecured creditors on Thursday, July 02, 2026 at 11:30 AM at The Music Academy, Chennai, to consider a Scheme of Amalgamation with Dr. Agarwal's Health Care Limited (AHCL). Under the scheme, AEHL (transferor) will merge into AHCL (transferee), which already holds a 72.67% stake in AEHL. BSE and NSE had earlier issued no-objection/observation letters in February 2026, and the scheme was approved by the Board on August 27, 2025. AEHL operates 63+ eye care facilities supported by 250+ doctors, while AHCL runs 288 facilities across 14 Indian states and 5 UTs, plus 19 facilities in Africa, making it India's largest eye care chain by FY2024 revenue. Remote e-voting via NSDL runs from June 07, 2026 (9:00 AM) to July 01, 2026 (5:00 PM), with the cut-off date set as December 31, 2025. The merger is expected to be EPS accretive from the first year of implementation.

Likely market impact

If approved by the requisite majority (three-fourths in value of unsecured creditors voting), AEHL will merge into its listed parent AHCL, simplifying the group structure and consolidating operations into a single stronger entity. Shareholders of AEHL should expect a share swap based on the PwC and Bansi S. Mehta valuation report dated August 26, 2025.